GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Lymphocyte activation antigen CD30) (CD antigen CD30)

 TNR8_RAT                Reviewed;         492 AA.
P97525; A0A0G2K7Z6;
27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
03-JUL-2019, sequence version 2.
03-JUL-2019, entry version 111.
RecName: Full=Tumor necrosis factor receptor superfamily member 8 {ECO:0000250|UniProtKB:P28908};
AltName: Full=CD30L receptor;
AltName: Full=Lymphocyte activation antigen CD30;
AltName: CD_antigen=CD30 {ECO:0000250|UniProtKB:P28908};
Flags: Precursor;
Name=Tnfrsf8 {ECO:0000312|RGD:3879};
Synonyms=Cd30 {ECO:0000250|UniProtKB:P28908};
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116;
[1]
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
INDUCTION.
STRAIN=WKAH; TISSUE=T-cell lymphoma;
PubMed=8982082; DOI=10.1016/S0378-1119(96)00542-2;
Aizawa S., Satoh H., Horie R., Ito K., Choi S.H., Takeuchi H.,
Watanabe T.;
"Cloning and characterization of a cDNA for rat CD30 homolog and
chromosomal assignment of the genomic gene.";
Gene 182:155-162(1996).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=Brown Norway;
PubMed=15057822; DOI=10.1038/nature02426;
Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
Collins F.S.;
"Genome sequence of the Brown Norway rat yields insights into
mammalian evolution.";
Nature 428:493-521(2004).
-!- FUNCTION: Receptor for TNFSF8/CD30L. May play a role in the
regulation of cellular growth and transformation of activated
lymphoblasts (By similarity). Regulates gene expression through
activation of NF-kappa-B (PubMed:8982082).
{ECO:0000250|UniProtKB:P28908, ECO:0000269|PubMed:8982082}.
-!- SUBUNIT: Interacts with TRAF1, TRAF2, TRAF3 and TRAF5.
{ECO:0000250|UniProtKB:P28908}.
-!- SUBCELLULAR LOCATION: Cell membrane
{ECO:0000250|UniProtKB:P28908}; Single-pass type I membrane
protein {ECO:0000255}.
-!- TISSUE SPECIFICITY: Very low level of expression. Detected in
spleen, thymus and lung. Highly expressed in HTLV-1 infected T-
cell lines. {ECO:0000269|PubMed:8982082}.
-!- INDUCTION: By phytohemagglutinin (PHA) in spleen T-cells.
{ECO:0000269|PubMed:8982082}.
-!- SIMILARITY: Belongs to the TNFR8 family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; D42117; BAA07699.1; -; mRNA.
EMBL; AC127855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
PIR; JC5486; JC5486.
RefSeq; NP_062008.1; NM_019135.1.
SMR; P97525; -.
BioGrid; 247144; 2.
STRING; 10116.ENSRNOP00000022967; -.
PaxDb; P97525; -.
PRIDE; P97525; -.
Ensembl; ENSRNOT00000085929; ENSRNOP00000074409; ENSRNOG00000016782.
GeneID; 25069; -.
KEGG; rno:25069; -.
UCSC; RGD:3879; rat.
CTD; 943; -.
RGD; 3879; Tnfrsf8.
eggNOG; ENOG410IZAX; Eukaryota.
eggNOG; ENOG410YM0N; LUCA.
GeneTree; ENSGT00510000049215; -.
HOGENOM; HOG000220871; -.
InParanoid; P97525; -.
KO; K05145; -.
OrthoDB; 630149at2759; -.
PhylomeDB; P97525; -.
Reactome; R-RNO-5669034; TNFs bind their physiological receptors.
PRO; PR:P97525; -.
Proteomes; UP000002494; Chromosome 5.
Proteomes; UP000002494; Unplaced.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:RGD.
GO; GO:0007165; P:signal transduction; IEA:InterPro.
CDD; cd13409; TNFRSF8; 1.
InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
InterPro; IPR020416; TNFR_8.
InterPro; IPR034002; TNFRSF8_N.
PRINTS; PR01923; TNFACTORR8.
SMART; SM00208; TNFR; 3.
PROSITE; PS50050; TNFR_NGFR_2; 1.
2: Evidence at transcript level;
Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
Membrane; Phosphoprotein; Receptor; Reference proteome; Repeat;
Signal; Transmembrane; Transmembrane helix.
SIGNAL 1 18 {ECO:0000255}.
CHAIN 19 492 Tumor necrosis factor receptor
superfamily member 8.
/FTId=PRO_0000034576.
TOPO_DOM 19 282 Extracellular. {ECO:0000305}.
TRANSMEM 283 303 Helical. {ECO:0000255}.
TOPO_DOM 304 492 Cytoplasmic. {ECO:0000305}.
REPEAT 57 104 TNFR-Cys 1. {ECO:0000255|PROSITE-
ProRule:PRU00206}.
REPEAT 105 141 TNFR-Cys 2. {ECO:0000255|PROSITE-
ProRule:PRU00206}.
MOD_RES 334 334 Phosphoserine.
{ECO:0000250|UniProtKB:P28908}.
MOD_RES 348 348 Phosphoserine.
{ECO:0000250|UniProtKB:P28908}.
CARBOHYD 151 151 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 178 178 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 224 224 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 58 80 {ECO:0000255|PROSITE-ProRule:PRU00206}.
DISULFID 83 96 {ECO:0000255|PROSITE-ProRule:PRU00206}.
DISULFID 86 104 {ECO:0000255|PROSITE-ProRule:PRU00206}.
DISULFID 123 141 {ECO:0000255|PROSITE-ProRule:PRU00206}.
CONFLICT 67 67 S -> N (in Ref. 1; BAA07699).
{ECO:0000305}.
CONFLICT 75 78 NEDR -> SNEDG (in Ref. 1; BAA07699).
{ECO:0000305}.
CONFLICT 142 142 D -> E (in Ref. 1; BAA07699).
{ECO:0000305}.
CONFLICT 283 283 S -> T (in Ref. 1; BAA07699).
{ECO:0000305}.
CONFLICT 309 309 R -> W (in Ref. 1; BAA07699).
{ECO:0000305}.
CONFLICT 422 422 V -> A (in Ref. 1; BAA07699).
{ECO:0000305}.
SEQUENCE 492 AA; 52613 MW; 1D4A80FA1A247950 CRC64;
MSILLKAAGL LFLGMLQAFP KDRPLDTTCT GDLSYYPGEA ARNCCYQCPS GLSPTQPCPQ
GPATARSSVI LTTTNEDRKC TACVTCLPGL VEKAPCSGNS PRICECQPGM YCSTPAVNSC
ARCSEKTVVK FPDTAEKNTI CDLPSPGSGP NGSNPDDCKT LTSHTTPQAI PTLESPANDS
VRSLLPKQVT DFVNEGATKL VKVPESSSSK ASMPSPDPGN AEMNMTLKLP PPGTVPDIST
SENSMEPAST ASTLSLLVDA RTSSRMQPTS PLSTGTPFLD PGSMLFWVAM VVLLVGSASF
LLCYWKACRR RFQRKFHLNY LQQTFQPKME QVDSCPTEKL TQLQRSGSVT DSSAGHTLSP
LSPPAVETGA SVGTACLETL PLLDDSITGN SFAPREPPEP RVSTEHTNNR IEKIYIMKAD
TVIVGSVKTE VPEGRAPVGS TESELEAELE VDHTPHYPEQ ETEPPLGSCT EVMFSVEEGG
KEDHEPTTVS EK


Related products :

Catalog number Product name Quantity
E0020h ELISA kit CD30,CD30L receptor,D1S166E,Homo sapiens,Human,Ki-1 antigen,Lymphocyte activation antigen CD30,TNFRSF8,Tumor necrosis factor receptor superfamily member 8 96T
U0020h CLIA CD30,CD30L receptor,D1S166E,Homo sapiens,Human,Ki-1 antigen,Lymphocyte activation antigen CD30,TNFRSF8,Tumor necrosis factor receptor superfamily member 8 96T
E0020h ELISA CD30,CD30L receptor,D1S166E,Homo sapiens,Human,Ki-1 antigen,Lymphocyte activation antigen CD30,TNFRSF8,Tumor necrosis factor receptor superfamily member 8 96T
E0020r ELISA Cd30,CD30L receptor,Lymphocyte activation antigen CD30,Rat,Rattus norvegicus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
E0020r ELISA kit Cd30,CD30L receptor,Lymphocyte activation antigen CD30,Rat,Rattus norvegicus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
U0020r CLIA Cd30,CD30L receptor,Lymphocyte activation antigen CD30,Rat,Rattus norvegicus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
15-288-21411A Tumor necrosis factor receptor superfamily member 8 - CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Polyclonal 0.1 mg
15-288-21411A Tumor necrosis factor receptor superfamily member 8 - CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Polyclonal 0.05 mg
E0020m ELISA kit CD30L receptor,Lymphocyte activation antigen CD30,Mouse,Mus musculus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
E0020m ELISA CD30L receptor,Lymphocyte activation antigen CD30,Mouse,Mus musculus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
U0020m CLIA CD30L receptor,Lymphocyte activation antigen CD30,Mouse,Mus musculus,Tnfrsf8,Tumor necrosis factor receptor superfamily member 8 96T
20-783-70806 RAT ANTI MOUSE CD30 FITC - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
20-783-70800 MOUSE ANTI HUMAN CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
20-783-71494 MOUSE ANTI HUMAN CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.2 ml
20-783-71941 MOUSE ANTI HUMAN CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.2 mg
20-783-70802 MOUSE ANTI HUMAN CD30 RPE - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 100 TESTS
20-783-71493 MOUSE ANTI HUMAN CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 1 ml
20-783-71943 MOUSE ANTI HUMAN CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
20-783-71942 MOUSE ANTI HUMAN CD30 FITC - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
20-783-70801 MOUSE ANTI HUMAN CD30 FITC - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 100 TESTS
20-783-70809 RAT ANTI MOUSE CD30 Azide Free - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 1 mg
20-783-70808 RAT ANTI MOUSE CD30 RPE - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 100 TESTS
20-783-70805 RAT ANTI MOUSE CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.25 mg
20-783-70807 RAT ANTI MOUSE CD30 - Ki-1; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
20-272-191880 CD30 - Mouse monoclonal [HRS-4] to CD30; CD30L receptor; Lymphocyte activation antigen CD30; KI-1 antigen Monoclonal 0.1 mg
Pathways :
WP2328: Allograft rejection
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP444: Signaling of Hepatocyte Growth Factor Receptor
WP94: Signaling of Hepatocyte Growth Factor Receptor
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP949: Toll-like receptor signaling pathway
WP1354: B Cell Receptor Signaling Pathway
WP2292: Chemokine signaling pathway
WP783: Androgen Receptor Signaling Pathway
WP1130: T Cell Receptor Signaling Pathway
WP474: Endochondral Ossification
WP1161: TGF-beta Receptor Signaling Pathway
WP566: canonical wnt - zebrafish
WP1384: Toll-like receptor signaling pathway
WP2355: Corticotropin-releasing hormone
WP1004: Kit Receptor Signaling Pathway
WP147: Kit Receptor Signaling Pathway
WP26: Signal Transduction of S1P Receptor
WP590: Cardiovascular Signaling

Related Genes :
[CD27 TNFRSF7] CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27)
[FAS APT1 FAS1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[Faslg Apt1Lg1 Cd95l Fasl Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Fas Apt1 Tnfrsf6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[CD40 TNFRSF5] Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)
[Fas Apt1 Tnfrsf6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[CD40LG CD40L TNFSF5 TRAP] CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form]
[TNFRSF14 HVEA HVEM UNQ329/PRO509] Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)
[Tnfsf11 Opgl Rankl Trance] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[TNFSF11 OPGL RANKL TRANCE] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[Tnfrsf14 hvem] Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)
[TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738] Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[TNFRSF13B TACI] Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267)
[CD80 CD28LG CD28LG1 LAB7] T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80)
[Tnfrsf21 Dr6] Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358)
[TRAF2 TRAP3] TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)
[TNFRSF11A RANK] Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265)
[Sirpa Bit Myd1 Ptpns1 Shps1 Sirp] Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (mSIRP-alpha1) (p84) (CD antigen CD172a)
[CD44 LHR MDU2 MDU3 MIC4] CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44)
[TNFRSF17 BCM BCMA] Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)
[NGFR TNFRSF16] Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271)
[TNFRSF21 DR6 UNQ437/PRO868] Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358)
[SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP] Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a)
[CD86 CD28LG2] T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86)
[TNFSF14 HVEML LIGHT UNQ391/PRO726] Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand) (HVEM-L) (Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form]
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[Ptprc Ly-5] Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (Lymphocyte antigen 5) (Ly-5) (T200) (CD antigen CD45)
[SLC3A2 MDU1] 4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)
[Ceacam1 Bgp Bgp1] Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (Biliary glycoprotein D) (MHVR1) (Murine hepatitis virus receptor) (MHV-R) (CD antigen CD66a)

Bibliography :